Introduction to immune checkpoints – the new hot target for cancer immunotherapy
Development of therapeutic antibodies against immune checkpoints for the treatment of melanoma and other cancers is gaining momentum among academia and the pharmaceutical industry. If you are interested in the rising potential of activating the immune system to treat cancer, please join this webinar. We will provide a general introduction to immune checkpoint research and to our immune checkpoint stable cell lines. Then we will explore how these stable cell lines can be applied for therapeutic antibody generation. Recent data from screening immune checkpoint inhibitors with these stable cell lines will also be discussed.
|Introduction to immune checkpoints – the new hot target for cancer immunotherapy|
|Immune Checkpoint Stable Cell Lines||GPCR Stable Cell Lines|